The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical relevance of genetic mutations on treatment response to the demethylating agents in myelodysplastic syndromes.
Hyun Ae Jung
No relevant relationships to disclose
Chi Hoon Maeng
No relevant relationships to disclose
Chul Won Jung
No relevant relationships to disclose
Jun Ho Jang
No relevant relationships to disclose